Products Affected - Description
Dextran 40, Hospira
10% in 500 mL 5% Dextrose, 12 count (NDC 00409-7418-03)
10% in 500 mL 0.9% Sodium Chloride, 12 count (NDC 00409-7419-03)
Reason for the Shortage
Hospira states the reason for the shortage is manufacturing delay.
No presentations are available.
Estimated Resupply Dates
Hospira has Dextran 40 in 5% dextrose and Dextran 40 in 0.9% sodium chloride on back order and the company estimates a release date of 2nd quarter 2015 for Dextran 40 in 5% dextrose and cannot estimate a release date for Dextran 40 in 0.9% sodium chloride.
December 12, 2014; October 16, 2014; August 25, 2014; August 13, 2014; July 1, 2014; May 27, 2014, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins